Board Member
Sarepta Therapeutics, Inc. (SRPT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Douglas Ingram is recorded as CEO and Board Member at Sarepta Therapeutics, Inc. (SRPT). The proxy statement of Sarepta Therapeutics, Inc. reports total compensation of $1,387,072 for Douglas Ingram in fiscal 2019, including a base salary of $650,000. Disclosed compensation is on record for 3 fiscal years. Douglas Ingram has spoken on 5 earnings calls across 1 company, most recently for Sarepta Therapeutics, Inc. on July 16, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2017-01-01–present
Recorded roles and call appearances connecting this person to public companies.
CEO, Board Member
2017-01-01–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Sarepta Therapeutics, Inc. (SRPT) | President and Chief Executive Officer ^^ | $650,000 | $1,387,072 |
| 2018 | Sarepta Therapeutics, Inc. (SRPT) | President and Chief Executive Officer ^^ | $650,000 | $1,433,872 |
| 2017 | Sarepta Therapeutics, Inc. (SRPT) | President and Chief Executive Officer ^^ | $337,500 | $56,866,241 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
